Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

被引：2
|
作者：
Liu, Yang
Bell, Taylor
Zhang, Hui
Sun, Yuting
Li, Carrie J.
Feng, Ningping
Huang, Shengjian
Guo, Hui
Wang, Jack
Ahmed, Makhdum
Zhang, Victoria
Lam, Laura T.
Nomie, Krystle
Zhang, Liang
Di Francesco, Maria E.
Marszalek, Joe
Wang, Michael
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.290.290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
290
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting PRMT5 to Circumvent Acquired Ibrutinib Resistance in Mantle Cell Lymphoma
    Sloan, Shelby
    Brown, Fiona
    Chung, Ji Hyun
    Prouty, Alexander
    Wheeler, Esther
    Harrington, Bonnie K.
    Brooks, Eric
    Yilmaz, Ayse S.
    Ozer, Hatice G.
    Byrd, John C.
    Chen-Kiang, Selina
    Di Liberto, Maurizio
    Lapalombella, Rosa
    Vaddi, Kris
    Scherle, Peggy
    Youssef, Youssef
    Baiocchi, Robert A.
    Alinari, Lapo
    BLOOD, 2019, 134
  • [2] Statins in Combination with Ibrutinib bypasses Resistance to Ibrutinib in Mantle Cell Lymphoma
    Al-Zebeeby, Aoula
    Abbas, Ali
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2023, 9 (03): : 193 - 196
  • [3] Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic Reprogramming Towards Oxphos
    Nomie, Krystle
    Zhang, Liang
    Yao, Yixin
    Liu, Yang
    Zhang, Shaojun
    Zhang, Hui
    Guo, Hui
    Ahmed, Makhdum
    Badillo, Maria
    Wang, Linghua
    Wang, Michael
    BLOOD, 2018, 132
  • [4] Overcoming Mantle Cell Lymphoma's Ibrutinib Resistance
    Sinha, Gunjan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
  • [5] Overcoming primary ibrutinib resistance in mantle cell lymphoma
    Zhang, Leo
    Lan Pham
    Zhang, Hui
    Xie, Jingmeng
    Tao, Wenjing
    Bell, Taylor
    Chen, Zhihong
    Nomie, Krystle
    Fang, Bingliang
    Wang, Michael
    CANCER RESEARCH, 2016, 76
  • [6] CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma
    Viktoria Fuhr
    Shanice Heidenreich
    Mugdha Srivastava
    Angela Riedel
    Johannes Düll
    Elena Gerhard-Hartmann
    Andreas Rosenwald
    Hilka Rauert-Wunderlich
    Cell Death Discovery, 8
  • [7] Targeting Kinome Reprogramming for Overcoming Ibrutinib-Resistance (IR) in Mantle Cell Lymphoma (MCL)
    Zhao, Xiaohong
    Jiang, Huijuan
    Wang, Michelle
    Li, Tao
    Gao, Jing
    Lwin, Tint
    Ren, Yuan
    Sotomayor, Eduardo
    Shah, Bijal D.
    Tao, Jianguo
    BLOOD, 2018, 132
  • [8] Ibrutinib for mantle cell lymphoma
    Tucker, David L.
    Rule, Simon A.
    FUTURE ONCOLOGY, 2016, 12 (04) : 477 - 491
  • [9] Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Nomie, Krystle
    Zhang, Shaojun
    Liu, Yang
    Guo, Hui
    Huang, Shengjian
    Wang, Jeffrey
    Lopez, Elyse
    Zhang, Hui
    Lorence, Elizabeth A.
    Merolle, Maria
    Balaji, Swathi
    Ahmed, Makhdum
    Jiang, Changying
    Wang, Linghua
    Wang, Michael
    BLOOD, 2017, 130
  • [10] Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Jiang, Changying
    Yan, Fangfang
    McIntos, Joseph
    Jordan, Alexa A.
    Li, Yijing
    Che, Yuxuan
    Cai, Qingsong
    Wang, Wei
    Nie, Lei
    Wang, Michael
    BLOOD, 2021, 138
12345